| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.12.08 | Sapiens Announces Payment of Third Installment of the Principal Amount of Debentures | 20 | PR Newswire | CARY, North Carolina, December 7 /PRNewswire-FirstCall/ -- Sapiens International Corporation N.V. , a member of the Formula Group , today announced that it has paid the third installment of the principal... ► Artikel lesen | |
| 07.12.08 | Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL | 30 | PR Newswire | SAN FRANCISCO, Dec. 7 /PRNewswire-FirstCall/ -- Results of the Phase 2 clinical trial of R788 (fostamatinib disodium) in patients with relapsed or refractory B-Cell non-Hodgkin's lymphoma (NHL) will... ► Artikel lesen | |
| 07.12.08 | Rentrak Theatrical Announces Box Office Estimates for Weekend of December 7, 2008 | 25 | PR Newswire | LOS ANGELES, Dec. 7 /PRNewswire-FirstCall/ -- Rentrak Theatrical, a business unit of Rentrak Corporation , today announced the weekend theatrical box office estimates for the weekend period of December... ► Artikel lesen | |
| 07.12.08 | First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting | 70 | PR Newswire | CHESHIRE, Conn., Dec. 7 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. for the treatment of paroxysmal nocturnal hemoglobinuria... ► Artikel lesen | |
| 07.12.08 | DAIICHI SANKYO Initiates Phase III Trial of its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation | 21 | PR Newswire | TOKYO, MUNICH, Germany and EDISON, New Jersey, December 7 /PRNewswire/ --
- ENGAGE-AF TIMI 48 Trial to Study 16,500 Patients in More Than 1,400
Centers Globally
DAIICHI SANKYO Company... ► Artikel lesen | |
| 07.12.08 | Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology | 21 | PR Newswire | SAN FRANCISCO, Dec. 7 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. today announced the presentation of new data from two ongoing clinical trials demonstrating that the company's novel drug... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 7.390 |
| TESLA | 3.657 |
| NVIDIA | 1.944 |
| TUI | 1.523 |
| NEL | 1.382 |
| SUPER MICRO COMPUTER | 1.302 |
| VARTA | 1.168 |
| META PLATFORMS | 1.108 |
| RHEINMETALL | 1.082 |
| BAYER | 1.076 |
| INFINEON | 1.052 |
| DEUTSCHE BANK | 1.029 |
| AIXTRON SE | 957 |
| RENK GROUP | 913 |
| BYD | 776 |
| PLUG POWER | 762 |
| BASF | 712 |
| COMMERZBANK | 646 |
| DEUTSCHE LUFTHANSA | 593 |
| RWE | 578 |
| THYSSENKRUPP | 528 |
| ALLIANZ | 513 |
| MERCEDES-BENZ | 500 |
| VOLKSWAGEN | 466 |
| DEUTSCHE TELEKOM | 445 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
